Heparins and 2019-nCoV infection: a narrative review.
Sign Up to like & getrecommendations! Published in 2021 at "European review for medical and pharmacological sciences"
DOI: 10.26355/eurrev_202105_25842
Abstract: OBJECTIVE Patients with 2019-nCoV infection have a high risk to develop venous thrombotic events. Several guidelines recommend the use of either unfractionated heparin or low molecular weight heparins in preventing thrombotic events in these patients.… read more here.
Keywords: 2019 ncov; heparins 2019; narrative review; review ... See more keywords